Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3658)
All Articles published online
|
Publishing Process of This Article
|
Nov 24, 2021 (publication date) through Sep 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Buti S, Bersanelli M, Massari F, De Giorgi U, Caffo O, Aurilio G, Basso U, Carteni G, Caserta C, Galli L, Boccardo F, Procopio G, Facchini G, Fornarini G, Berruti A, Fea E, Naglieri E, Petrelli F, Iacovelli R, Porta C, Mosca A. First-line pazopanib in patients with advanced non-clear cell renal carcinoma: An Italian case series. World J Clin Oncol 2021; 12(11): 1037-1046 [PMID: 34909398 DOI: 10.5306/wjco.v12.i11.1037] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v12/i11/1037.htm |
| Number | Citing Articles |
| 1 |
Davide Bimbatti, Francesco Pierantoni, Eleonora Lai, Melissa Ballestrin, Nicolò Cavasin, Elisa Erbetta, Chiara De Toni, Umberto Basso, Marco Maruzzo. Advanced Non-Clear Cell Renal Cell Carcinoma Treatments and Survival: A Real-World Single-Centre Experience. Cancers 2023; 15(17): 4353 doi: 10.3390/cancers15174353
|
| 2 |
Catalin Baston, Andreea Ioana Parosanu, Ioana-Miruna Stanciu, Cornelia Nitipir. Metastatic Kidney Cancer: Does the Location of the Metastases Matter? Moving towards Personalized Therapy for Metastatic Renal Cell Carcinoma. Biomedicines 2024; 12(5): 1111 doi: 10.3390/biomedicines12051111
|
| 3 |
Nathaniel R. Wilson, Yusuf Acikgoz, Elshad Hasanov. Advances in non‐clear cell renal cell carcinoma management: From heterogeneous biology to treatment options. International Journal of Cancer 2024; 154(6): 947 doi: 10.1002/ijc.34756
|
| 4 |
Hasan Cagri Yildirim, Ertuğrul Bayram, Elvin Chalabiyev, Nargız Majidova, Tugay Avci, Halil Göksel Güzel, Caner Kapar, Mehmet Uzun, Perihan Perkin, Fahri Akgül, Saadet Sim Yildirim, Seda Sali, Anil Yildiz, Seher Nazli Kazaz, Engin Hendem, Murat Arcagok, Gulnihal Tufan, Umit Yildirim, Omer Faruk Akgul, Çagatay Arslan, Hakan Taban, Eren Sahin, Melek Caglayan, Ramazan Esen, Berna Öksüzoğlu, Deniz Can Guven, Muhammet Ali Kaplan, Murat Araz, Mert Basaran, Erdem Cubukcu, Erhan Gokmen, Irfan Cicin, Efnan Algin, Huseyin Salih Semiz, Deniz Tural, Banu Ozturk, Atike Pinar Erdogan, Murat Sari, Oguz Kara, Mustafa Erman. Comparison of the efficacy of sunitinib and pazopanib in patients with advanced non-clear renal cell carcinoma. Journal of Chemotherapy 2024; : 1 doi: 10.1080/1120009X.2024.2403051
|